Ads
related to: hcv polymerase inhibitors for diabetes mellitus patients pictures in images- Discussion Guide PDF
Check Out The Healthcare
Professional Discussion Guide.
- Get Tested Today
Find A Testing Location Near You.
See Additional Info.
- Real Patients With Hep C
See Patient Testimonials For
A Hep C Treatment Option.
- Find A Local Doctor
Find A Healthcare Professional Near
You To Discuss Treatment Options
- Learn About Savings
Cost Shouldn't Get In The Way Of
Getting Treated. There Are Options.
- Download Resources
Use These Resources With Your
Healthcare Professional.
- Discussion Guide PDF
Search results
Results From The WOW.Com Content Network
The virus is internalized and the nucleocapsid is released into the cytoplasm of the hepatocyte after binding with the receptor. The NS5B protein, which is an RNA-dependent RNA polymerase, catalyzes hepatitis C virus replication. [10] The hepatitis C virus can cause acute infection but most patients are asymptomatic upon exposure.
HCV genome. Nonstructural protein 5B (NS5B) is a viral protein found in the hepatitis C virus (HCV). [1] It is an RNA-dependent RNA polymerase, having the key function of replicating HCV's viral RNA by using the viral positive RNA strand as a template to catalyze the polymerization of ribonucleoside triphosphates (rNTP) during RNA replication.
It is also possible that NS5A is a critical component during HCV replication and subcellular localization, which may shed light on the poorly understood HCV life cycle. [ 1 ] [ 4 ] Additionally, NS5A has been shown to modulate the polymerase activity of NS5B , an RNA-dependent RNA polymerase (RdRp) . [ 3 ]
HCV is a positive-sense single-stranded RNA virus that has been demonstrated to replicate in the hepatocytes of both humans and chimpanzees. A single HCV polyprotein is translated, and then cleaved by cellular and viral proteases into three structural proteins (core, E1, and E2) and seven nonstructural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B).
It acts as a NS5b polymerase inhibitor. [1] [2] [3] References This page was last edited on 23 March 2024, at 09:51 (UTC). Text is available under ...
The first protease inhibitor approved by the U.S. Food and Drug Administration (FDA). Ritonavir: Norvir: AbbVie: U.S. patent 5,541,206: March 1, 1996: AbbVie was part of Abbott Laboratories when patent was granted. As well as being a protease inhibitor in its own right, ritonavir inhibits the breakdown of other protease inhibitors.
Ads
related to: hcv polymerase inhibitors for diabetes mellitus patients pictures in images